Grant: Alliance Grants
Université de Montréal
$24,800.00
Role of MHC class II molecule pairing in antigen presentation and disease
FY 2024-25
Summary
MHC molecules are responsable for scanning the body and sample all the proteins present in cells and tissues. Mechanisms are in place to distinguish if the MHC-bound proteins are of self or non-self origin. Foreign material will ignite an immune response to protect the host from the invader. In this context, MHC molecules must thus travel through various cellular locations and ultimatly reach the cell surface to present its findings to patrolling T cells.
The class II molecules of the MHC are formed by the association of two chaines, called alpha and beta. Our collaborator at the Albany College of Medicine in NY has found that there are different means by which the transmembrane regions of these alpha and beta chains can fold together. This imposes subtle but concrete structural differences in the proteins. These subsets were called M1 and M2.
As MHC class II molecules have a great clinical impact, for example in infectious diseases, auto-immunity and organ transplantation, we propose to use a proximity ligation assay to further characterize the M1 and M2 subsets. Our hypothesis is that some proteins specifically interact with M1 or M2 MHC class II molecules. By defining those proteins (interactome), we will better understand the specific roles of M1 and M2 subsets. Eventually, this basic research may lead to the development of therapeutics to prevent human diseases.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
592693-2024
Name nom
Thibodeau, Jacques J
Department département
Microbiologie, infectiologie et immunologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
24800
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Role of MHC class II molecule pairing in antigen presentation and disease
Keywords
autoimmunity; cancer; cell biology; immunology; inflammation; protein folding; protein function; protein structure; protein trafficking; vaccines
Application summary
MHC molecules are responsable for scanning the body and sample all the proteins present in cells and tissues. Mechanisms are in place to distinguish if the MHC-bound proteins are of self or non-self origin. Foreign material will ignite an immune response to protect the host from the invader. In this context, MHC molecules must thus travel through various cellular locations and ultimatly reach the cell surface to present its findings to patrolling T cells.
The class II molecules of the MHC are formed by the association of two chaines, called alpha and beta. Our collaborator at the Albany College of Medicine in NY has found that there are different means by which the transmembrane regions of these alpha and beta chains can fold together. This imposes subtle but concrete structural differences in the proteins. These subsets were called M1 and M2.
As MHC class II molecules have a great clinical impact, for example in infectious diseases, auto-immunity and organ transplantation, we propose to use a proximity ligation assay to further characterize the M1 and M2 subsets. Our hypothesis is that some proteins specifically interact with M1 or M2 MHC class II molecules. By defining those proteins (interactome), we will better understand the specific roles of M1 and M2 subsets. Eventually, this basic research may lead to the development of therapeutics to prevent human diseases.